AU4027097A - Creation of Inventions and Patents with Artificial Intelligence

AU4027097A – Method of treatment
– Google Patents

AU4027097A – Method of treatment
– Google Patents
Method of treatment

Info

Publication number
AU4027097A

AU4027097A
AU40270/97A
AU4027097A
AU4027097A
AU 4027097 A
AU4027097 A
AU 4027097A
AU 40270/97 A
AU40270/97 A
AU 40270/97A
AU 4027097 A
AU4027097 A
AU 4027097A
AU 4027097 A
AU4027097 A
AU 4027097A
Authority
AU
Australia
Prior art keywords
treatment
Prior art date
1996-09-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU40270/97A
Inventor
Birgitta Brunes
Christian Brunes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Scotia Holdings PLC

Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-09-03
Filing date
1997-09-01
Publication date
1998-03-26

1997-09-01
Application filed by Scotia Holdings PLC
filed
Critical
Scotia Holdings PLC

1998-03-26
Publication of AU4027097A
publication
Critical
patent/AU4027097A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

A61K31/19—Carboxylic acids, e.g. valproic acid

A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid

A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/33—Heterocyclic compounds

A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

A61K31/404—Indoles, e.g. pindolol

A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

AU40270/97A
1996-09-03
1997-09-01
Method of treatment

Abandoned

AU4027097A
(en)

Applications Claiming Priority (3)

Application Number
Priority Date
Filing Date
Title

GBGB9618341.3A

GB9618341D0
(en)

1996-09-03
1996-09-03
Method of treatment

GB9618341

1996-09-03

PCT/GB1997/002349

WO1998009623A2
(en)

1996-09-03
1997-09-01
Use of cholinergic drugs

Publications (1)

Publication Number
Publication Date

AU4027097A
true

AU4027097A
(en)

1998-03-26

Family
ID=10799318
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU40270/97A
Abandoned

AU4027097A
(en)

1996-09-03
1997-09-01
Method of treatment

Country Status (4)

Country
Link

AU
(1)

AU4027097A
(en)

GB
(1)

GB9618341D0
(en)

WO
(1)

WO1998009623A2
(en)

ZA
(1)

ZA977867B
(en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP1814532B1
(en)

1999-05-27
2012-01-18
George F. El Khoury
Topical application of muscarinic and opioid agents for treatment of tinnitus

GB2355191A
(en)

1999-10-12
2001-04-18
Laxdale Ltd
Combination formulations for fatigue, head injury and strokes

EP1190709A1
(en)

2000-09-21
2002-03-27
Tinnitus Forschungs- und Entwicklungs GmbH
Treatment of tinnitus

GB0216027D0
(en)

2002-07-10
2002-08-21
Arachnova Therapeutics Ltd
New therapeutic use

WO2011058366A1
(en)

2009-11-12
2011-05-19
Acacia Pharma Limited
Use of bethanechol for treatment of xerostomia

GB201107533D0
(en)

2011-05-06
2011-06-22
Acacia Pharma Ltd
Formulaiton

Family Cites Families (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4857534A
(en)

1984-04-05
1989-08-15
North Carolina State University
Method of maintaining ruminants on high energy low fiber diet

US5668117A
(en)

1991-02-22
1997-09-16
Shapiro; Howard K.
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments

WO1994001108A1
(en)

1992-07-02
1994-01-20
Theratech, Inc.
Controlled release pilocarpine delivery system

JP2852608B2
(en)

1994-06-27
1999-02-03
雪印乳業株式会社

Xerostomia treatment

1996

1996-09-03
GB
GBGB9618341.3A
patent/GB9618341D0/en
active
Pending

1997

1997-09-01
WO
PCT/GB1997/002349
patent/WO1998009623A2/en
active
Application Filing

1997-09-01
AU
AU40270/97A
patent/AU4027097A/en
not_active
Abandoned

1997-09-02
ZA
ZA9707867A
patent/ZA977867B/en
unknown

Also Published As

Publication number
Publication date

GB9618341D0
(en)

1996-10-16

WO1998009623A3
(en)

1998-08-27

ZA977867B
(en)

1998-05-27

WO1998009623A2
(en)

1998-03-12

Contact information